Nedocromil sodium: A review of the evidence for a dual mechanism of action

Clinical and Experimental Allergy

Volumn 30, Issue 4, 2000, Pages 461-468

  Corin, R E ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEDOCROMIL SODIUM;

ALLERGIC CONJUNCTIVITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; DRUG MECHANISM; EOSINOPHIL; HUMAN; HUMAN CELL; IMMEDIATE TYPE HYPERSENSITIVITY; MAST CELL; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALS; ANTI-ALLERGIC AGENTS; CONJUNCTIVITIS, ALLERGIC; HUMANS; NEDOCROMIL;

EID: 0034059051     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2000.00769.x     Document Type: Review

References (59)

1. 1 Sampson AP, Church MK. Signaling in mast cells. In: Denburg JA, ed. Allergy and Allergic Diseases: the New Mechanisms and Therapeutics. Totowa: Human Press Inc., 1998:385-93.
2. 2 Bonini S, Bonini S. Pathogenesis of allergic conjunctivitis. In: Denburg JA, ed. Allergy and Allergic Disease: the New Mechanisms and Therapeutics. Totowa: Human Press., 1998:509-19.
3. 3 Maurer D, Fiebiger E, Reininger B et al. Expression of high affinity IgE receptors (Fc R1) on monocytes of atopic individuals. J Exp Med 1994; 179:745-75.
4. 4 Abelson MB, Madiwale N, Weston JH. Conjunctival eosinophils in allergic ocular disease. Arch Ophthalmol 1983; 101:555-6.
5. 5 Walsh GM, Hartnell A, Wardlaw AJ, Kurihara K, Sanderson CJ, Kay AB. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leukocyte integrin (CD11/ 18) -dependent manner. Immunology 1990; 71:258-65.
6. 6 Walsh GM, Mermod J-J, Hartnell A, Kay AB, Wardlaw AJ. Human eosinophil, but not neutrophil, adherence to IL-1-stimulated human umbilical vascular endothelial cells is alpha-4 beta-1 (very late antigen-4) dependent. J Immunol 1991; 146:3419-23.
7. 7 Simon H-U, Blaser K. Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia? Trends Immunol 1995; 16:53-5.
8. 8 Konderman L, van der Bruggen T, Schweizer RC et al. Eosinophil priming by cytokines: from cellular signal to in vivo modulation. Eur Respir J 1996; 9 (Suppl. 22):119s-25s.
9. 9 MacGlashan D. Signaling in human basophils. In: Denburg JA, ed. Allergy and Allergic Disease: the Mechanisms and Therapeutics. Totowa: Human Press Inc., 1998:402-13.
10. 10 Kurata H, Arai K-I. Hematopoetic cytokines. In: Denburg JA, ed. Allergy and Allergic Disease: the New Mechanism and Therapeutics. Totowa: Human Press Inc., 1998:328-47.
11. 11 Kita H. Eosinophil signal transduction. In: Denburg JA, ed. Allergy and Allergic Disease: the New Mechanisms and Therapeutics. Totowa: Human Press Inc., 1998:312-41.
12. 12 Skedinger MC, Augustine NH, Morris EZ, Neilson DW, Zimmerman GA, Hill HR. Effect of disodium cromoglycate on neutrophil movement and intracellular calcium concentration. J Allergy Clin Immunol 1987; 80:573-7.
13. 13 Sorkin EM, Ward A. Ocular sodium cromoglycate: an overview of its therapeutic efficacy in allergic eye disease. Drugs 1986; 31:131-48.
14. 14 Stock EL, Bielory L. Treatment of ocular allergy. Immunol All Clin N Am 1997; 17:75-88.
15. 15 Knottnerus IG, Scot CN, Riley PA. Nedocromil sodium 2% ophthalmic solution (TILAVIST): a new topical treatment for ocular allergic inflammation. Ocular Immunol Inflam 1993; 1:27-30.
16. 16 Kjellman N-IM, Stevens MT. Clinical experience with Tilavist: an overview of efficacy and safety. Allergy 1995; 50:14-22.
17. 17 Youngchaiyud P, Lee TB. Effect of nedocromil on the immediate response to antigen challenge in asthmatic patients. Clin Allergy 1986; 16:129-34.
18. 18 Leung KBP, Flint KC, Brostoff J et al. Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells. Thorax 1988; 43:756-61.
19. 19 Moqbel R, Cromwell O, Walsh GM, Wardlaw AJ, Kurlak L, Kay AB. Effects of nedocromil sodium (Tilade) on the activation of human eosinophils and neutrophils and the release of histamine from mast cells. Allergy 1988; 43:268-76.
20. 20 Napier FE, Shearer MA, Temple DM. Nedocromil sodium inhibits antigen-induced contraction of human lung parenchymal and bronchial strips, and the release of sulphidopeptide-leukotrienes and histamine from human lung fragments. Br J Pharmacol 1990; 100:247-50.
21. 21 Dahlen S-E, Bjorck T, Kumlin M et al. Dual inhibitory action of nedocromil sodium on antigen-induced inflammation. Drugs 1989; 37 (Suppl. 1):63-9.
22. 22 Yanni JM, Miller ST, Gamache DA, Spellman J, Xu S, Sharif NA. Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells. Ann Allergy Asthma Immunol; 1997; 79:541-5.
23. 23 Eady RP. The pharmacology of nedocromil sodium. Eur J Respir Dis 1986; 69 (Suppl. 147):112-9.
24. 24 Brodie D, Marquardt D, Wasserman S. Effect of nedocromil sodium and sodium cromoglycate on connective tissue and bone marrow derived mast cells: acute and chronic studies. Eur J Respir Dis 1986; 69 (Suppl. 147):196-8.
25. 2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells. J Immunol 1986; 137:3941-5.
26. 26 Bissonnette EY, Enciso JA, Befus AD. Inhibition of tumor necrosis factor-alpha (TNF-α) release from mast cells by the anti-inflammatory drugs, sodium cromoglycate and nedocromil sodium. Clin Exp Immunol 1995; 102:78-84.
27. 27 Irani A-M, Schwartz LB. Mast cell heterogeneity. Clin Exp Allergy 1989; 19:143-55.
28. 28 Okayama Y, Benyon RC, Rees PH, Lowman MA, Hillier K, Church MK. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. Clin Exp Allergy 1992; 22:401-9.
29. 29 Louis RE, Radermecker MF. Substance P-induced histamine release from human basophils, skin and lung fragments: effect of nedocromil sodium and theophylline. Int Arch Allergy Appl Immunol 1990; 92:329-33.
30. 30 Enerback L, Bergstrom S. Effect of nedocromil sodium on the compound exocytosis of mast cells. Drugs 1989; 37 (Suppl. 1):44-50.
31. 31 Moqbel R, Walsh GM, Kay AB. Inhibition of human granulocyte activation by nedocromil sodium. Eur J Respir Dis 1986; 69 (Suppl. 147):227-9.
32. 32 Moqbel R, Cromwell O, Kay AB. The effect of nedocromil sodium on human eosinophil activation. Drugs 1989; 37 (Suppl. 1):19-22.
33. 33 Bruijnzeel PLB, Warringa RAJ, Kok PTM, Kreukneit J. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate. Br J Pharmacol 1990; 99:798-802.
34. 34 Warringa RAJ, Mengelers HJJ, Maikoe TM, Bruijnzeel PLB, Konderman L. Inhibition of cytokine-primed eosinophil chemotaxis by nedocromil sodium. J Allergy Clin Immunol 1993; 91:802-9.
35. 35 Hutson PA, Holgate ST, Church MK. Inhibition by nedocromil sodium of early and late phase bronchoconstriction and airway cellular infiltration provoked by ovalbumin inhalation in conscious sensitized guinea-pigs. Br J Pharmacol 1988; 94:6-8.
36. 4 generation by nedocromil sodium. J Allergy Clin Immunol 1992; 90:202-9.
37. 4 in human eosinophils stimulated by unopsonized zymosan and the calcium ionophore A23187: the effects of nedocromil sodium. J Allergy Clin Immunol 1990; 85:26-35.
38. 38 Resler B, Sedgwick B, Busse WW. J Allergy Clin Immunol 1992; 89:A362.
39. 39 Frigas E, Loegering DA, Gleich GJ. Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab Invest 1980; 42:35-43.
40. 40 Ayars GH, Altman LC, Mcmanus MM et al. Injurious effect of the eosinophil peroxidase-hydrogen peroxidase-halide system and major basic protein on human nasal epithelium in vitro. Am Rev Respir Dis 1989; 140:125-31.
41. 41 Motojima S, Frigas E, Loegering DA, Gleich GJ. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis 1989; 139:801-5.
42. 42 Spry CJ, Kumaraswami V, Tai P-C. The effect of nedocromil sodium on secretion from human eosinophils. Eur J Respir Dis 1986; 69 (Suppl. 147):241-3.
43. 43 Devalia JL, Sapsford RJ, Rusznak C, Davies R. The effect of human eosinophils on cultured human nasal epithelial cell activity and the influence of nedocromil sodium in vitro. Am J Respir Cell Mol Biol 1992; 7:270-7.
44. 44 Yukawa T, Read RC, Kroegel C et al. The effects of activated eosinophils and neutrophils on guinea pig airway epithelium in vitro. Am J Respir Cell Mol Biol 1990; 2:341-53.
45. 45 Bruijnzeel PLB, Warringa RAJ, Kok PTM. Inhibition of platelet-activating factor-and zymosan-activated serum-induced chemotaxis of human neutrophils by nedocromil sodium, BN 52021 and sodium cromoglycate. Br J Pharmacol 1989b; 97:1251-7.
46. 46 Bruinjnzeel PLB, Hamelink ML, Kok PTM, Kreukniet J. Nedocromil sodium inhibits the A23187-and opsonized zymosan-induced leukotriene formation by human eosinophils but not by human neutrophils. Br J Pharmacol 1989a; 96:631-6.
47. 47 Bradford PG, Rubin RP. The differential effects of nedocromil sodium and sodium cromoglycate on the secretory response of rabbit peritoneal neutrophils. Eur J Respir Dis 1986; 69 (Suppl. 147):238-40.
48. 48 Lucas A, Shuster S. Cromolyn inhibition of protein kinase C activity. Biochem Pharmacol 1987; 36:562-5.
49. 49 Church MK, Hutson PA, Holgate ST. Effect of nedocromil sodium on early and late phase responses to allergen challenge in the guinea-pig. Drugs 1989; 37 (Suppl. 1):101-8.
50. 50 Pretolani M, Lefort J, Silva P et al. Protection by nedocromil sodium of active immunization-induced bronchopulmonary alterations in the guinea pig. Am J Respir Dis 1990; 141:1259-65.
51. 51 Schellenberg RR, Ishida K, Thomson RJ. Nedocromil sodium inhibits airway hyperresponsiveness and eosinophilic infiltration induced by repeated antigen challenge in guinea-pigs. Br J Pharmacol 1991; 103:1842-6.
52. 52 Pretolani M, Lefort J, Vargaftig B. Inhibition by nedocromil sodium of recombinant human interleukin-5-induced lung hyperresponsiveness to platelet-activating factor in actively sensitized guinea pigs. J Allergy Clin Immunol 1993; 91:809-16.
53. 53 Manolitsas ND, Wang J, Devalia JL, Trigg CJ, McCauley AE, Davies RJ. Regular albuterol, nedocromil sodium, and bronchial inflammation in asthma. Am J Respir Care Med 1995; 151:1925-30.
54. 54 Riley PA, Mather ME, Keogh RW, Eady RP. Activity of nedocromil sodium in mast cell-dependent reactions in the rat. Int Arch Allergy Appl Immunol 1987; 82:108-10.
55. 55 Peng B, Li Q, Luyo D, Whitcup SM, Roberge FG, Chan C-C. Treatment of allergic conjunctivitis in murine model. In: Nussenblatt RB, Whitcup SM, Caspi RR, Grey I, eds. Advances in Ocular Immunology. New York, NY: Elsevier Science, 1994:249-52.
56. 56 Merayo-Lloves J, Zhao TZ, Dutt JE, Foster CS. A new murine model of allergic conjunctivitis and effectiveness of nedocromil sodium. J All Clin Immunol 1996; 97:1129-40.
57. 57 Javdan P, Figini M, Ricciardolo FLM, Geppetti P. Nedocromil sodium and sodium cromoglycate inhibit plasma extravasation in the guinea-pig conjunctiva. Ocular Immunol Inflam 1995; 3:37-44.
58. 58 Verin PH, Dicker ID, Mortemousque B. Nedocromil sodium eye drops are more effective than sodium cromoglycate eye drops for the long-term management of vernal keratoconjunctivitis. Clin Exp Allergy 1999; 29:429-36.
59. 59 Calonge M, Montero JA, Herreras JM, Juberias JR, Pastor JC. Efficacy of nedocromil sodium and cromolyn sodium in an experimental model of ocular allergy. Ann Allergy Asthma Immunol 1996; 77:124-30.